EAPC Premium Access

Young Investigators Award Population Science and Public Health

Event: ESC Preventive Cardiology 2022
Topic: Risk Factors and Prevention
Session type: Award Sessions
Date: 9 April 2022
Time: 11:00 - 11:45

Session

Become an EAPC member to access this resource

Become a member

Already a member? Sign in

6 presentations in this session

Cardiovascular disease risk factors and outcomes of acute myocardial infarction in young adults in two nationwide cohorts in the united states

Speaker: Mr V. Mishra (Mumbai, IN)
Thumbnail

Gender bias in the primary prevention of cardiovascular disease

Speaker: Miss H. Kang (Southampton, GB)
Thumbnail

Acute and long-term mortality rates among participants of mass-participation sport events versus the general population.

Speaker: Doctor E. Bakker (Nijmegen, NL)
Thumbnail

A new angle on atrial fibrillation risk prediction; the role of P-wave axis in future AF

Speaker: Doctor R. Chattopadhyay (Cambridge, GB)
Thumbnail

Genetic risk score for risk stratification of patients positive for SARS-CoV-2 virus. The CARGENCORS study.

Speaker: Miss A. Camps-Vilaro (Barcelona, ES)
Thumbnail

Impact of physical inactivity on cardiovascular mortality in united states: county-level analysis from 2011 to 2019

Speaker: Doctor S. Abohashem (Boston, US)
Thumbnail

6 speakers from this session

Mr Vinayak Mishra

Sir JJ Group of Hospitals, Mumbai (India)
0 follower

Miss Hanya-Vaisakhi Kang

University of Southampton, Southampton (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Esmee Bakker

Radboud Institute for Health Sciences, Nijmegen (Netherlands (The))
0 follower

Doctor Rahul Chattopadhyay

Cambridge University Hospital NHS Trust, Cambridge (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Miss Anna Camps-Vilaro

Hospital del Mar Medical Research Institute (IMIM), Barcelona (Spain)
0 follower

Doctor Shady Abohashem

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk